Initial or continuous coculture with umbilical cord-derived mesenchymal stromal cells facilitates in vitro expansion of human regulatory T-cell subpopulations
Stem Cells Translational Medicine · 31.05.2025 · 14 (6)
DOI: 10.1093/stcltm/szaf012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 14.06.2025. Verfasst von Qifeng Ou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Institute (REMEDI) at CÚRAM Research Ireland Centre for Medical Devices, School of Medicine, University of Galway, Galway H19 T…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, T-Lymphocytes, Regulatory, Umbilical Cord. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council PhD Fellowship, Irish Clinical Academic Training (ICAT) Programme, Wellcome Trust.
Abstract (Originalsprache)
Clinical trials have demonstrated the safety and potential efficacy of ex vivo expanded regulatory T cells (Tregs) for immune-mediated diseases. Nonetheless, achieving consistent and timely Treg yield and purity remains challenging. We aimed to evaluate the potential to enhance culture expansion of primary human total Treg (CD4+/CD25+/CD127lo) and Treg subpopulations through coculture with human umbilical cord-derived mesenchymal stromal cells (hUC-MSCs). In 14- to 21-day anti-CD3/anti-CD28-, interleukin-2-, and rapamycin-containing cultures, fluorescence-activated cell sorting (FACS)-purified total Treg underwent 4-fold greater expansion following hUC-MSC coculture. Potency to suppress T effector cell (Teff) proliferation was equivalent for hUC-MSC-cocultured and control Tregs and correlated with the expression of HLA-DR, CD39, and inducible costimulator (ICOS). The impact of hUC-MSC coculture on ex vivo expansion of 3 FACS-purified Treg subpopulations [CD45RA+ (Subtype I), CD45RA−HLA-DR+ (Subtype II), and CD45RA−HLA-DR− (Subtype III)] was then investigated. Both initial and continuous hUC-MSC coculture yielded significantly higher fold expansion of each Treg subpopulation compared to control. However, the magnitude of enhancement was substantially greater for non-naive (Subtypes II and III) than for naive (Subtype I) Treg. Coculture with hUC-MSC increased HLA-DR expression of all 3 expanded Treg subpopulations while maintaining comparable Teff suppressive potency. For non-naive Treg (Subtypes II and III), both initial and continuous hUC-MSC coculture also increased the final %Foxp3+ and %Helios+. Thus, coculture with clinical-grade hUC-MSC substantially enhances the ex vivo yield, preserves the suppressive potency, and modulates HLA-DR expression of FACS-purified Treg subpopulations with greatest effect on non-naive (CD45RA−) Treg. The findings have potential to facilitate identification, functional characterization, and manufacturing of Treg subpopulations with distinct therapeutic benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Regenerative Medicine Institute (REMEDI) at CÚRAM Research Ireland Centre for Medical Devices, School of Medicine, University of Galway, Galway H19 TK33, Ireland.
- Flow Cytometry Core Facility, Biomedical Sciences, University of Galway, Galway H19 TK33, Ireland.
- School of Biological and Chemical Sciences, College of Science and Engineering, University of Galway, Galway H19 TK33, Ireland.
- Department of Applied Science, Technological University of the Shannon, Limerick V94 EC5T, Ireland.
- Orbsen Therapeutics Ltd., Dangan, Galway H91 A3EF, Ireland.
- Biology and Biopharmaceutical Science, Department of Science, South East Technological University, Waterford X91 CF21, Ireland.
ORCID-Profile: Qifeng Ou, Matthew D Griffin
Förderung
- China Scholarship Council PhD Fellowship
- Irish Clinical Academic Training (ICAT) Programme
- Wellcome Trust
- Health Research Board
- Health Service Executive National Doctors Training and Planning
- Health and Social Care Research and Development Division
- Health Service Executive of Ireland
- Irish Research Council Enterprise Partnership Postdoctoral Fellowship
Zitieren
APA
Ou, Q., Cormican, S., Power, R., Hontz, S., Hanley, S. A., Islam, M. N., Shaw, G., Deedigan, L. M., Horan, E., Elliman, S. J., Fazekas, B., Krawczyk, J., Negi, N., & Griffin, M. D. (2025). Initial or continuous coculture with umbilical cord-derived mesenchymal stromal cells facilitates in vitro expansion of human regulatory T-cell subpopulations. Stem Cells Translational Medicine, 14(6). https://doi.org/10.1093/stcltm/szaf012
Vancouver
Ou Q, Cormican S, Power R, Hontz S, Hanley SA, Islam MN, et al. Initial or continuous coculture with umbilical cord-derived mesenchymal stromal cells facilitates in vitro expansion of human regulatory T-cell subpopulations. Stem Cells Translational Medicine. 2025;14(6). doi:10.1093/stcltm/szaf012
BibTeX
@article{Ou2025,
author = {Ou, Qifeng and Cormican, Sarah and Power, Rachael and Hontz, Sarah and Hanley, Shirley A and Islam, Md Nahidul and Shaw, Georgina and Deedigan, Laura M and Horan, Emma and Elliman, Stephen J and Fazekas, Barbara and Krawczyk, Janusz and Negi, Neema and Griffin, Matthew D},
title = {Initial or continuous coculture with umbilical cord-derived mesenchymal stromal cells facilitates in vitro expansion of human regulatory T-cell subpopulations},
journal = {Stem Cells Translational Medicine},
year = {2025},
volume = {14},
number = {6},
doi = {10.1093/stcltm/szaf012}
}
EUVIMED